Biotech co. developing psychedelics for medical use starts trading on NASDAQ
Atai CEO and co-founder Florian Brand on his biotech company going public.
Friday, June 18, 2021
Biotech co. developing psychedelics for medical use starts trading on NASDAQ
Biotech co. developing psychedelics for medical use starts trading on NASDAQ
Atai CEO and co-founder Florian Brand on his biotech company going public.
0 comments:
Post a Comment